Nanodelivery of traditional Chinese Gingko Biloba extract EGb-761 and bilobalide BN-52021 induces superior neuroprotective effects on pathophysiology of heat stroke
- PMID: 34560923
- DOI: 10.1016/bs.pbr.2021.06.007
Nanodelivery of traditional Chinese Gingko Biloba extract EGb-761 and bilobalide BN-52021 induces superior neuroprotective effects on pathophysiology of heat stroke
Abstract
Military personnel often exposed to high summer heat are vulnerable to heat stroke (HS) resulting in abnormal brain function and mental anomalies. There are reasons to believe that leakage of the blood-brain barrier (BBB) due to hyperthermia and development of brain edema could result in brain pathology. Thus, exploration of suitable therapeutic strategies is needed to induce neuroprotection in HS. Extracts of Gingko Biloba (EGb-761) is traditionally used in a variety of mental disorders in Chinese traditional medicine since ages. In this chapter, effects of TiO2 nanowired EGb-761 and BN-52021 delivery to treat brain pathologies in HS is discussed based on our own investigations. We observed that TiO2 nanowired delivery of EGb-761 or TiO2 BN-52021 is able to attenuate more that 80% reduction in the brain pathology in HS as compared to conventional drug delivery. The functional outcome after HS is also significantly improved by nanowired delivery of EGb-761 and BN-52021. These observations are the first to suggest that nanowired delivery of EGb-761 and BN-52021 has superior therapeutic effects in HS not reported earlier. The clinical significance in relation to the military medicine is discussed.
Keywords: Blood-brain barrier; Brain edema; Brain pathology; EGb-761; Gingko Biloba; Heat stroke; Hyperthermia; Nanowired delivery; Neuroprotection.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare no conflict of interest with any entity mentioned here.
Similar articles
-
TiO2-Nanowired Delivery of Chinese Extract of Ginkgo biloba EGb-761 and Bilobalide BN-52021 Enhanced Neuroprotective Effects of Cerebrolysin Following Spinal Cord Injury at Cold Environment.Adv Neurobiol. 2023;32:353-384. doi: 10.1007/978-3-031-32997-5_9. Adv Neurobiol. 2023. PMID: 37480466 Review.
-
Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S8-14. doi: 10.1055/s-2003-40454. Pharmacopsychiatry. 2003. PMID: 13130383 Review.
-
Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection.Neuroscience. 2011 Apr 28;180:248-55. doi: 10.1016/j.neuroscience.2011.02.031. Epub 2011 Feb 18. Neuroscience. 2011. PMID: 21334424 Free PMC article.
-
Antioxidant compounds EGB-761 and BN-520 21 attenuate heat shock protein (HSP 72 kD) response, edema and cell changes following hyperthermic brain injury. An experimental study using immunohistochemistry in the rat.Amino Acids. 2000;19(1):339-50. doi: 10.1007/s007260070065. Amino Acids. 2000. PMID: 11026505
-
Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia.Brain Res. 2001 Dec 20;922(2):282-92. doi: 10.1016/s0006-8993(01)03188-2. Brain Res. 2001. PMID: 11743961
Cited by
-
Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer's Disease Brain Pathology Exacerbated by Sleep Deprivation.Adv Neurobiol. 2023;32:3-53. doi: 10.1007/978-3-031-32997-5_1. Adv Neurobiol. 2023. PMID: 37480458 Review.
-
Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine.Adv Sci (Weinh). 2024 Apr;11(16):e2308677. doi: 10.1002/advs.202308677. Epub 2024 Feb 28. Adv Sci (Weinh). 2024. PMID: 38419366 Free PMC article. Review.
-
TiO2-Nanowired Delivery of Chinese Extract of Ginkgo biloba EGb-761 and Bilobalide BN-52021 Enhanced Neuroprotective Effects of Cerebrolysin Following Spinal Cord Injury at Cold Environment.Adv Neurobiol. 2023;32:353-384. doi: 10.1007/978-3-031-32997-5_9. Adv Neurobiol. 2023. PMID: 37480466 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources